These include nausea, loose stools or diarrhea, constipation, mild abdominal cramping or bloating, reduced appetite beyond the therapeutic goal, mild fatigue, and injection site reactions such as temporary redness or tenderness
doi: 10.1097/SGA.0b013e31819de3e0 21 LiangQQShiZJYuanTChenSYLiYPZhangHRet al
Metabolic impacts of dual therapy with semaglutide and orlistat in individuals with obesity: Insights from clinical trials
Data from research firm Pharmarack shows the market grew over 15% in January, led by Eli Lillys Mounjaro, which posted Rs 112 crore in sales
At En Vogue IV Therapy & Wellness Clinic, we treat a large number of patients suffering from type 2 diabetes and obesity, two illnesses that frequently coexist and exacerbate one another
If dizziness persists, discuss with your healthcare provider before considering compression stockings or adjusting any blood pressure medications